Crk Like Protein (CRKL) Peptide

Este producto es parte de CRKL-Crk-like protein
Product Graph
195€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Crk Like Protein (CRKL) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx269087
tested applications
P-ELISA

Description

Crk Like Protein (CRKL) Peptide is a synthetic peptide. This peptide is used in the production of

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Crk Like Protein (CRKL)
Host
Synthetic
Assay Type
Activity: Not tested.
Sequence Fragment: C-Terminus: C-KIFDPQNPDENE
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Size 1
100 µg
Form
Lyophilized
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
1399
NCBI Accession
NP_005198.1
Alias
CRK like proto-oncogene, crk-like protein
Background
Protein CRKL
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reconstitute in deionized water.

Descripción

Related Products

abx007367

Crk Like Protein (CRKL) Antibody

CRKL Antibody is a Rabbit Polyclonal Antibody against CRKL.

Ver Producto
abx012058

Crk-Like Protein (CRKL) Antibody

This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.

Ver Producto
abx027457

Crk-Like Protein (CRKL) Antibody

This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.

Ver Producto